Author

Richard F. Pollock

Observed names: R Pollock, Richard Pollock

Institution: Covalence Research

Observed institution: Covalence Research

ORCID: 0000-0002-9873-7507

Observed ORCID: 0000-0002-9873-7507

OpenAlex ID: A5079049104

Research and development absorptive capacity: a Māori perspective

2019 · Katharina Ruckstuhl, Maria Amoamo, et al. · Kōtuitui New Zealand Journal of Social Sciences Online · 10

Long-Term Cost-Effectiveness of an Advanced Hybrid Closed-Loop Automated Insulin Delivery System Versus Multiple Daily Insulin Injections Plus Continuous Glucose Monitoring in Adults with Type 1 Diabetes in Australia

2026 · Sarah Glastras, Meaghan Read, et al. · Advances in Therapy

Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan

2026 · Hirotaka Watada, Shiro Tanaka, et al. · Journal of Diabetes Investigation

Cost‐effectiveness analysis of Dexcom ONE + real‐time continuous glucose monitoring versus self‐monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand

2026 · Ryan G. Paul, Jessica Y. Matuoka, et al. · Diabetes Obesity and Metabolism

Author response for "Cost-effectiveness analysis of Dexcom ONE+ Real-time Continuous Glucose Monitoring versus Self-monitoring of Blood Glucose in People with Type 2 Diabetes in Aotearoa New Zealand"

2026 · Ryan G. Paul, Jessica Y. Matuoka, et al. · Publons reviews and discussion

Budget Impact of Advanced Insulin Delivery Systems for the Management of Type 1 Diabetes

2026 · Danila Fava, Asli Zeynep Ozdemir Saltik, et al. · Diabetes Technology & Therapeutics

Author response for "Cost-effectiveness analysis of Dexcom ONE+ Real-time Continuous Glucose Monitoring versus Self-monitoring of Blood Glucose in People with Type 2 Diabetes in Aotearoa New Zealand"

2025 · Ryan G. Paul, Jessica Y. Matuoka, et al. · Publons reviews and discussion

EE77 Optimizing Treatment Pathways for nAMD: Balancing Durability and Costs in the UK

2024 · T Shering, I Rickard, et al. · Value in Health

POSA319 Development of a Diminishing Marginal Disutility Model for Intravenous Iron Infusions Based on Data from a Time Trade-Off Study in China

2022 · D Wu, Y Zhang, et al. · Value in Health

Works count: 9

Citation count: 10

H-index: 1

I10-index: 1